scholarly article | Q13442814 |
P50 | author | Md Imam Uddin | Q42783120 |
P2093 | author name string | Jason R Buck | |
H Charles Manning | |||
Eliot T McKinley | |||
Joel M Harp | |||
Dewei Tang | |||
Allie Fu | |||
Michael L Nickels | |||
Matthew R Hight | |||
P2860 | cites work | 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. | Q43737788 |
Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation | Q46119208 | ||
Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand | Q46614777 | ||
Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine | Q48705414 | ||
Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation | Q80140819 | ||
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function | Q24296269 | ||
Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states | Q24631648 | ||
PET radiotracers: crossing the blood-brain barrier and surviving metabolism | Q33585028 | ||
Microwave-assisted Organic Synthesis of a High-affinity Pyrazolo-pyrimidinyl TSPO Ligand | Q33650978 | ||
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation | Q34171364 | ||
Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa). | Q34382894 | ||
Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline | Q34522608 | ||
Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. | Q36081687 | ||
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands. | Q37835335 | ||
Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer | Q39769015 | ||
Targeted molecular imaging agents for cellular-scale bimodal imaging | Q40491443 | ||
[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis | Q41863477 | ||
Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia | Q42414802 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3429-3433 | |
P577 | publication date | 2013-04-03 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging | |
P478 | volume | 56 |
Q46709105 | 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. |
Q41556036 | A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of Neuroinflammation |
Q33897006 | Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3). |
Q39181546 | Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging |
Q47361841 | Evaluation of the novel TSPO radiotracer [18F] VUIIS1008 in a preclinical model of cerebral ischemia in rats. |
Q34175347 | Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer |
Q50460970 | Highly facile and regio-selective synthesis of pyrazolo[1,5-a]pyrimidines via reactions of 1,2-allenic ketones with aminopyrazoles |
Q33840012 | Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. |
Q33624653 | Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations |
Q41446521 | New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO. |
Q55456900 | Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma. |
Q35827097 | Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study |
Q35213599 | Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma |
Q48810894 | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor--[(18)F]Fluorooctyl Fenbufen Amide--For Imaging of Brain Tumors. |
Q38221277 | The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy. |
Q42077880 | Toward hyperpolarized molecular imaging of HIV: synthesis and longitudinal relaxation properties of (15) N-Azidothymidine |
Q33624586 | Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases |
Q38949384 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1). |
Search more.